HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma
Abstract Lung adenocarcinoma is one of the most frequent tumor subtypes, involving changes in a variety of oncogenes and tumor suppressor genes. Hydroxysteroid 17-Beta Dehydrogenase 6 (HSD17B6) could synthetize dihydrotestosterone, abnormal levels of which are associated with progression of multiple...
Saved in:
Main Authors: | Tian Tian, Fu Hong, Zhiwen Wang, Jiaru Hu, Ni Chen, Lei Lv, Qiyi Yi |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2f71137f25e447fc9f77fe05a1dd4ff5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Downregulation of the Proton-Activated Cl- Channel TMEM206 Inhibits Malignant Properties of Human Osteosarcoma Cells
by: Fei Peng, et al.
Published: (2021) -
Loss of DSTYK activates Wnt/β-catenin signaling and glycolysis in lung adenocarcinoma
by: Chenxi Zhong, et al.
Published: (2021) -
TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
by: Barbara Toffoli, et al.
Published: (2021) -
ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling
by: Yuan He, et al.
Published: (2021) -
Amino acid deprivation induces AKT activation by inducing GCN2/ATF4/REDD1 axis
by: Hyeon-Ok Jin, et al.
Published: (2021)